Back
Xylem, Inc. Vs. Keros Therapeutics, Inc. Industry Stock Comparison
Buy
58
XYL
Xylem, Inc.
Last Price:
$140.87
Seasonality Move:
1.18%
Sell
43
KROS
Keros Therapeutics, Inc.
Last Price:
$18.60
Seasonality Move:
1.1%
Buy
58
Xylem, Inc. (XYL)
is a Buy
Is Xylem, Inc. a Buy, Sell or Hold?
-
The current Xylem, Inc. [XYL] share price is $139.43. The Score for XYL is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
XYL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Keros Therapeutics, Inc. (KROS)
is a Sell
Is Keros Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Keros Therapeutics, Inc. [KROS] share price is $18.56. The Score for KROS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
KROS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XYL Stock Price Chart
What is Xylem, Inc.'s stock price today?
-
The Xylem, Inc. share price today is $139.43Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XYL is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Stock Price Chart
What is Keros Therapeutics, Inc.'s stock price today?
-
The Keros Therapeutics, Inc. share price today is $18.56Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.
XYL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.59 | Sell |
| Relative Strength Index (14 RSI): | 50.22 | Buy |
| Chaikin Money Flow: | -711106 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (137.19 - 139.85) | Buy |
| Bollinger Bands (100): | (138.63 - 147.39) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 42.83 | Sell |
| Chaikin Money Flow: | 156978 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.73 - 21.79) | Sell |
| Bollinger Bands (100): | (14.62 - 19.1) | Buy |
XYL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 138.48 | Buy |
| 20-day SMA: | 138.22 | Buy |
| 50-day SMA: | 142.26 | Sell |
| 200-day SMA: | 134.37 | Buy |
| 8-day EMA: | 138.86 | Buy |
| 20-day EMA: | 138.92 | Buy |
| 50-day EMA: | 140.62 | Sell |
| 200-day EMA: | 136.96 | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.74 | Sell |
| 20-day SMA: | 20.63 | Sell |
| 50-day SMA: | 18.34 | Buy |
| 200-day SMA: | 15.18 | Buy |
| 8-day EMA: | 19.35 | Sell |
| 20-day EMA: | 19.75 | Sell |
| 50-day EMA: | 18.71 | Sell |
| 200-day EMA: | 18.8 | Sell |
Xylem, Inc. Earnings Growth & XYL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.61 per share.
Keros Therapeutics, Inc. Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.27 per share, and a decrease next year of $0.80 per share.
Xylem, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics, Inc. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||